About ReBEC
The Brazilian Clinical Trials Registry (ReBEC) is an open-access virtual platform for registering experimental and non-experimental studies involving human beings conducted in Brazilian territory by Brazilian and foreign researchers. ReBEC is a joint project of the Ministry of Health (DECIT/MS), the Pan American Health Organization (PAHO), and the Oswaldo Cruz Foundation (FIOCRUZ). The Executive Committee of ReBEC is composed of the aforementioned institutions and the National Health Surveillance Agency (ANVISA). ReBEC is an important source of information for patients, healthcare professionals, researchers, companies, and research centers. Its support services feature generative artificial intelligence ReBEC@, the first artificial intelligence for clinical trial registration in the world. Learn more
Everything you need to know about ReBEC
Click to access the hotsite
Click to download the PDF version
Existing fast tracks and support for other studies will not be interrupted. Priority assistance is granted to accelerate clinical research in epidemiological emergency situations and/or studies with potential to reduce socioeconomic inequalities, keeping a perspective aligned with the forefront of ethics and transparency, health diplomacy, scientific collaboration, and the diversity and specificities of recruitment and healthcare. Fast-Tracks in Operation>>
Instructions for the Registrant
We recommend reading the Registrant's Manual.
1 - Register or log in and fill out the forms normally in Portuguese and English.
For English, if you experience any difficulty, use Google Translate
(or another free translation tool).
2 - Attach the mandatory ethics committee documentation and submit the form.
3 - Save the support number in your WhatsApp contacts. Send a message with your name and username.
It is not necessary or recommended to send your password.
4 - A reviewer will respond to you. Choose your preferred communication mode:
chat, audio recordings, or scheduled voice call.
5 - Your form will be reviewed in both languages. Follow further instructions to complete approval.
Clinical Research Volunteer
Would you like to become a volunteer in a clinical trial registered in ReBEC?
Access our FAQ to find out how.
Support channels:
* AI ReBEC@ (virtual assistant): automated support 24/7
* Humanized chat: Monday to Friday, from 8:00 AM to 12:00 PM (Brasília time), via this link
* Institutional WhatsApp / Dedicated Line: +55 21 97203-4750
Support from Monday to Friday, from 9:00 AM to 4:00 PM (Brasília time)
Priority and/or urgent administrative requests outside office hours may be sent to: plantao.rebec@gmail.com
We recommend including your username, associated email, or study registration number (RBR-xxxxxxx) with every request, when applicable, for faster assistance. Learn more
News
11/20/2026 | Lisa Henderson | BioXconomy
Executive says trial recruitment needs an upstream fix to keep pace with AI-driven discovery.
The clinical trials recruitment ecosystem is facing an infrastructure — if not existential — crisis that has nothing to do with finding new molecules and everything to do with finding the right patients. That is the core argument made by Dennis Akkaya, chief growth officer of myTomorrows, who insists that the system built for drug development is not designed to sustain the AI-fueled drug discovery world now emerging.
While AI has captured the industry’s drug discovery imagination for quite some time, investments have grown in neolabs, tech companies, pharma, small research labs, and more. A recent article from McKinsey & Company referenced investor funding in AI-enabled drug discovery reaching $8.40 billion in 2025, up from $4.10 billion in 2023, a compound annual growth rate of 43% since 2023. Most of that investment has yet to reach the clinic, but Akkaya argues the industry should prepare now for when it does. Every new candidate that emerges, however quickly it was discovered, will still need patients and clinical evidence to clear regulatory pathways. “Discovery may be getting faster,” he said. “Access to patients isn’t.”
“AI will super compress discovery to treatment, the question then is, how do patients get into a trial?” Akkaya told BioXconomy. Since the rise of personalized medicine years ago, trials have become more geographically dispersed, for ever-smaller patient populations, with more complex protocol criteria. In many therapeutic areas, protocols increasingly…
Username/Password
Public trial
Vasodilator Supplementation in strength training
Date of registration: 11/20/2026 (mm/dd/yyyy)Last approval date : 11/20/2026 (mm/dd/yyyy)
Last revision: 1
Study type: Interventional
Anxiety, Depression and quality of life assessment in patients with face fractures
Date of registration: 11/20/2026 (mm/dd/yyyy)Last approval date : 11/20/2026 (mm/dd/yyyy)
Last revision: 1
Study type: Observational
Analysis of protein alterations and mental disorders in patients undergoing cardiac surgery
Date of registration: 11/20/2026 (mm/dd/yyyy)Last approval date : 11/20/2026 (mm/dd/yyyy)
Last revision: 1
Study type: Observational
How Different Types of Physical Exercise Influence Blood Proteins and Recovery in People After a Stroke
Date of registration: 11/20/2026 (mm/dd/yyyy)Last approval date : 11/20/2026 (mm/dd/yyyy)
Last revision: 1
Study type: Interventional
Evaluation of the effects of therapeutic Laser on pain and quality of life in women with Fibromyalgia
Date of registration: 11/19/2026 (mm/dd/yyyy)Last approval date : 11/19/2026 (mm/dd/yyyy)
Last revision: 1
Study type: Interventional
Effect of an educational intervention on knowledge about the use of medicines to prevent blood clots in people with mechanical heart valves
Date of registration: 11/19/2026 (mm/dd/yyyy)Last approval date : 11/19/2026 (mm/dd/yyyy)
Last revision: 1
Study type: Interventional
Follow-up of gum healing after surgery to cover exposed tooth roots
Date of registration: 11/19/2026 (mm/dd/yyyy)Last approval date : 11/19/2026 (mm/dd/yyyy)
Last revision: 1
Study type: Observational
Total de Ensaios Clínicos 19341.
Existem 9882 ensaios clínicos registrados.
Existem 5312 ensaios clínicos recrutando.
Existem 149 ensaios clínicos em análise.
Existem 6384 ensaios clínicos em rascunho.